NCT00381238View on ClinicalTrials.gov

Open-Label Extension Assessing Long-Term Safety Of Rosiglitazone In Subjects With Mild To Moderate Alzheimer's Disease

PHASE2CompletedINTERVENTIONAL
Enrollment

33

Participants

Timeline

Start Date

June 20, 2006

Primary Completion Date

February 1, 2009

Study Completion Date

February 3, 2009

Conditions
Alzheimer's Disease
Interventions
DRUG

rosiglitazone

Extended Release Tablets

Trial Locations (7)

27705

GSK Investigational Site, Durham

48109

GSK Investigational Site, Ann Arbor

85006

GSK Investigational Site, Phoenix

85340

GSK Investigational Site, Litchfield Park

85351

GSK Investigational Site, Sun City

02478

GSK Investigational Site, Belmont

H4H 1R3

GSK Investigational Site, Montreal

Sponsors

Lead Sponsor

GlaxoSmithKline
All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY